CIAM
AGIO icon

Caitong International Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Caitong International Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,222
Closed -$549K – 2968
2026
Q1 		$549K Buy
16,222
+9,482
+141% +$269K 0.1% 188
2025
Q4 		$183K Buy
+6,740
New +$236K 0.05% 231
2025
Q3 		– Sell
-21
Closed -$698 – 1896
2025
Q2 		$698 Sell
21
-24
-53% -$727 ﹤0.01% 1648
2025
Q1 		$1.32K Sell
45
-714
-94% -$23.7K ﹤0.01% 1486
2024
Q4 		$24.9K Buy
+759
New +$35.7K 0.02% 721

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Caitong International Asset Management's AGIO Position: Q2 2026 in Review

Caitong International Asset Management sold out of Agios Pharmaceuticals (AGIO) in Q2 2026, closing a stake of 16,222 shares — an estimated $549K sold.

Caitong International Asset Management first reported a position in AGIO in Q4 2024 and held it in 5 quarters. The position peaked at $549K in Q1 2026. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Caitong International Asset Management reported no remaining Agios Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 16,222 Agios Pharmaceuticals shares in Q2 2026, an estimated $549K.
  • Caitong International Asset Management first reported a position in Agios Pharmaceuticals in Q4 2024 and held it in 5 quarters.
  • Caitong International Asset Management's Agios Pharmaceuticals position peaked at $549K in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.